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Abstract
The management of severe open fractures of the lower
leg continues to challenge the treating surgeon. Major
difficulties include high infection rates as well as ade-
quate temporary soft tissue coverage. In the past, these
injuries were commonly associated with loss of the
extremity. Today, vacuum therapy provides not only
safe temporary wound coverage but also conditioning
of the soft tissues until definitive wound closure.
Amongst other advantages, bacterial clearance and in-
creased formation of granulation tissue are attributed
to vacuum therapy, making it an extremely attractive
tool in the field of wound healing. However, despite its
clinical significance, which is underlined by a constantly
increasing range of indications, there is a substantial
lack of basic research and well-designed studies docu-
menting the superiority of vacuum therapy compared
to alternative wound dressings. Vacuum therapy has
been approved as an adjunct in the treatment of severe
open fractures of the lower leg, complementing re-
peated surgical debridement and soft tissue coverage
by microvascular flaps, which are still crucial in the
treatment of these limb-threatening injuries. Vacuum
therapy has in general proven useful in the manage-
ment of soft tissue injuries and, since it is generally well
tolerated and has low complication rates, it is fast
becoming the gold standard for temporary wound
coverage in the treatment of severe open fractures of
the lower leg.
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Introduction
The management of severe open fractures of the lower
leg remains a major challenge in surgery, and adequate
treatment of the concomitant soft tissue injury is of the
highest priority, since it determines the fate and out-
come of bone and extremity [1, 2]. In the past, open
wound treatment of fractures or osteosynthesis fol-
lowed by flap coverage was often associated with loss
of the extremity [3]. Additionally, higher complication
rates relating to microvascular flap loss and infections
hindered delayed reconstruction.
A variety of methods of temporary wound cover-
age before definitive wound closure have been de-
scribed; nowadays, vacuum-assisted closure (VACTM,
Kinetic Concepts, Inc., San Antonio, TX, USA) ther-
apy (VT) can be regarded as the wound care modality
in routine clinical use.
Simultaneously developed in the USA and Ger-
many in the late 1980s, VT has gained increasingly
widespread use over the past years, and the apparent
clinical significance of VT is underlined by a continu-
ously increasing range of indications in all surgical and
medical fields [4, 5]. Within this trend, multiple reports
have been published on the use of VT in open fractures
[2, 6, 7]. However, it must be stated that, despite the
widespread use of VT in the management of open
fractures and beyond, there is still a lack of solid evi-
dence in the literature on the superiority of VT com-
pared to alternative wound dressings, and the exact
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underlying mechanisms that lead to this apparent
improved wound healing remain largely unknown [4].
The aim of this review is to present the current
role and rationale of VT in the management of open
fractures of the lower leg. Besides general histo-
rical development and physiological/pathophysiological
mechanisms of VT, further consideration was given
to indications, contraindications, and complications
of VT in the management of these limb-threatening
injuries, based on the current literature and personal
experience.
Short History and Current Spectrum of Clinical
Use of Vacuum Therapy
For a long time, the application of negative pressure
has been a well-known surgical treatment option.
Originally, it was described as an alternative to pres-
sure dressings after radical mastectomy with the goal of
preventing serum collection and rapid tissue adapta-
tion [8].
In the early 1990s, Fleischmann et al. [6] reported
on a novel technique of soft tissue management in
open fractures using drainage tubes inserted into
polyvinyl foam, transparent polyurethane dressing
impermeable to bacteria, and vacuum bottles to pro-
duce negative pressure. The term ‘‘vacuum sealing’’
was established. In the mid-1990s, Argenta & Morykwas
[9, 10] further assessed the physiological mechanisms
of vacuum therapy in clinical and experimental studies.
This led to the development and patenting of the
vacuum-assisted closure device (VACTM, Kinetic
Concepts Inc., San Antonio, TX, USA). In contrast
to the latter, the resulting and currently used term
‘‘VACTM therapy’’ (VT) describes a dynamic and
controllable therapeutic system including variable
treatment parameters, as described below.
The option of temporary closure of soft tissue de-
fects using a simple technique was found to be very
attractive to a variety of clinicians. This led not only to
the widespread use of VT but also to the present dis-
crepancy between a broad range of clinical indications
based on reports of personal experience and cases as
well as other forms of non-peer-reviewed literature and
the lack of knowledge of the physiological mechanisms
of VT [4, 5, 11].
The first experiences with VT comparable to the
system used today were gained in the late 1980s and
reported in the early 1990s. In these, acute and septic
wounds were treated with this method [12–14], and
shortly afterwards chronic wounds such as crural ulcers
and decubitus ulcers were also treated [15]. There are
now a wide range of indications [4, 5, 11]. Severe
dermatological wounds as well as problematic wounds
in vascular surgery are treated by VT [16, 17]. Plastic
and reconstructive surgery has expanded its use of VT,
as burns of the hand and fixation of skin grafts in
particular have been shown to be ideal indications for
VT [18, 19]. In trauma and orthopedic surgery, the
range of indications has been extended to implant
infections in endoprosthetics and spinal surgery [20]. In
visceral surgery, entero- and lymphocutaneous fistulas
as well as open abdomens are treated with VT [21, 22].
Furthermore, VT is used not only for wounds and soft
tissue defects on the body surface but also for pathol-
ogies in the body cavity, such as bronchial stump
insufficiency or pancreatic trauma [23, 24].
Concept and Mechanism of Vacuum Therapy
Principle of Application
The vacuum-assisted closure (VACTM, Kinetic Con-
cepts, Inc., San Antonio, TX, USA) system is available
commercially. Principally, it consists of a polyurethane
ether foam sponge which is cut to fit directly over the
wound surface. The adhesive dressing is trimmed and
placed over the sponge to fix it in place. In addition, the
sponge may be secured to the wound edges using skin
staples or sutures. A small opening is then cut into the
adhesive dressing over the sponge. An evacuation tube
with a fenestrated distal end surrounded by an adhe-
sive dressing is then attached over that opening. The
fenestration at the end of the tube establishes com-
munication between the lumen of the tube and the
foam sponge. The proximal end of the evacuation tube
is then connected via a drainage canister to an adjust-
able vacuum pump. The pump creates suction that al-
lows subatmospheric pressure to be applied to the
entire wound surface. The foam sponge enables equal
distribution of the applied suction to the entire surface
of the wound. The drainage canister collects any fluid
that is extracted from the wound. The subatmospheric
pressure can be applied continuously or intermittently
with negative pressure up to 125 mmHg. Slight varia-
tions of the device based on this principle are now
available for different ranges of applications. Figure 1
shows a clinical example of a patient with an open
fracture of the lower leg treated by VT.
Specific Mechanisms of Vacuum Therapy
The subatmospheric pressure generated by VT has
been shown to have several effects on the wound sur-
face, leading to alteration of the physiological and
chemical milieu. Morykwas et al. [10] showed in a pig
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model that both intermittent as well as continuous
subatmospheric pressure increased granulation tissue
formation compared with control wounds.
The first mechanisms postulated for this increased
granulation tissue formation and wound response was
the resultant increase in local blood flow, which was
shown to be up to fourfold in this study.
The second mechanism assumed to contribute to
the observed granulation tissue formation was the
mechanical stress applied by VT to the wound surface,
as experimental studies have previously shown that
mechanical stress can induce tissue responses, includ-
ing cytokine release and cell proliferation [25–27]. It
was also shown that application of subatmospheric
pressure alters the cytoskeleton of the cells in the
wound bed [28]. This alteration then disrupts the
integrin bridges of the cytoskeleton, triggering the re-
lease of intracellular secondary messengers, which in
turn upregulate cell proliferation. Hence, the increased
rate of granulation tissue formation may be attributed
to this release of secondary messengers.
As local cellular and humoral components play an
important role during each phase of wound healing
[29], it can further be hypothesized that VT may cause
mechanically triggered immunomodulation as well
as neovascularization and/or angiogenesis. This was
Figures 1a to 1d. Clinical case of
vacuum therapy (VT) for severe
open fracture of the lower leg.
A 60-year-old polytraumatized
female patient presented with
a severe open fracture of the
lower leg. Initial debridement
and ‘‘second look’’ operations
resulted in a large soft tissue
and bony defect (a, b). The
fracture was initially stabilized
with external fixation and VT
was applied to the soft tissue
defect for temporary coverage
and conditioning (c). Plate
osteosynthesis of the tibia and
fibula was performed on day 6
and definitive wound closure
was performed using a free la-
tissimus dorsi microvascular
flap on day 8. Later on, the
external fixation was removed
after four weeks (d), and finally
autologous bone grafting was
performed after 6 weeks (e, f).
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corroborated by an initial study of our own group
demonstrating significantly increased levels of proin-
flammatory cytokines and growth factors in wound
fluids during VT as compared to alternative EpigardTM
dressing used as temporary wound coverage in a total
of 21 patients presenting with traumatic wounds [30].
Based on these results, the possible impact of VT on
local inflammation and neovascularization was further
assessed. In a more recent study including a total of 32
patients with traumatic wounds, our own group showed
not only significantly higher interleukin (IL)-8 and
vascular endothelial growth factor (VEGF) levels
in wound fluids during VT compared to alternative
EpigardTM dressings, but also increased neovasculari-
zation by CD31 and von Willebrand factor immuno-
histochemistry in wound biopsies. Additionally, there
was an accumulation of neutrophils and augmented
expression of VEGF in wound biopsies during VT [31].
These results demonstrated for the first time that
there is a selective and locally amplified humoral and
cellular immune reaction as well as accelerated neo-
vascularization during VT, suggesting that VT leads to
increased local IL-8 and VEGF concentrations, which
may trigger accumulation of neutrophils and angio-
genesis, thus accelerating neovascularization.
The third mechanism hypothesized to contribute to
the increased rate of granulation tissue formation
during VT is the effect of continuous suction on the
removal of inhibitory factors. Shi et al. [32] showed a
marked decrease of MMP-1-, MMP-2- as well as MMP-
13-mRNA during VT, meaning that removal of these
metalloproteases allows local growth factors to func-
tion more efficiently.
Finally, Morykwas et al. [10] showed that VT de-
creases the bacterial count of infected wounds to
levels that would allow for spontaneous healing within
4–5 days. Bacterial infection has been shown to alter
the physiological healing process by not only disrupting
and prolonging the inflammatory phase of wound
healing but also inhibiting the function of leukocytes
and the formation of granulation tissue [33]. The ability
of VT to decrease local bacterial count can be attrib-
uted to the three properties of increased blood flow,
decreased interstitial edema, and removal of harmful
enzymes from the wound [5].
Indications for Vacuum Therapy
The VT device can be applied to any type of tissue or
material, including soft tissues such as dermis, fat,
fascia, tendon, muscle and blood vessels, as well as
bone, synthetic mesh and hardware [5, 11]. The two
most important prerequisites are, on the one hand,
proper wound debridement to avoid the risk of pro-
moting a deeper or systemic infection and, on the other
hand, well-vascularized soft tissue, as further necrosis
is likely to occur at the wound edges if VT is applied to
an ischemic wound.
VT has greatly simplified wound management. It is
currently well accepted and widely used as an initial
dressing after wound debridement due to its above-
mentioned properties of reducing wound edema, con-
trolling local bacterial growth and promoting
granulation tissue formation. Altogether, VT provides
a safe temporary wound environment, allowing
reconstructive surgery and definitive wound closure to
be planned electively rather than preformed urgently.
In addition, there are several clinical studies which
indicate that the application of VT allows a less com-
plex mode of definitive wound closure, such as wound
healing by secondary intention or a simple split skin
graft rather than by microsurgical free flaps, to be
chosen [34, 35]. Furthermore, VT ideally prepares
wounds that are to be closed by delayed primary clo-
sure or with a local flap again by decreasing wound
edema and wound size and therefore facilitating
mobilization of the skin edges and reducing tension
when rotating or advancing a flap. For split skin grafts,
VT is both an excellent modality for stimulating the
wound to develop an adequate bed of granulation for
the graft and an ideal dressing for ensuring excellent
skin graft take [36].
Complications and Contraindications
of Vacuum Therapy
Generally, complications associated with VT are rare
and of low morbidity. However, serious events have
been reported initially, such as toxic shock syndrome
or enteric fistula [9, 37]. These were mostly related to
inadequate technique, incorrect application and man-
agement. In addition, hemodynamic instability is an-
other potential complication of VT, as large volumes of
fluid may be extracted from the wound depending on
the type, size and location of the wound. Less serious
complications associated with VT are pain, skin irri-
tation or maceration, pressure from the tubing, odor,
tissue necrosis, bleeding or infection. These affect up to
25% of patients during VT and can be avoided through
the use of the proper technique and appropriate
management and patient selection [5, 11].
Accordingly, there are a few contraindications to
VT that are described in the literature, which have
been corroborated by our personal experiences [5, 11].
They can be exclusively derived from the above com-
plications and include for example fragile, damageable
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skin and ischemic tissue as well as the presence of
malignancy [28]. VT should not be used in patients
with thin and sensitive skin due to age or chronic
corticosteroid use, as the skin may be sheared or
avulsed upon the removal of the adhesive tape during
dressing change. In open fractures, therefore, we prefer
to protect surrounding superficial skin abrasions and
contused or damaged wound edges that are not deb-
rided and are going to be observed for further
demarcation using hydrocolloid dressings, such as
Comfeel PlusTM transparent dressing (Coloplast, Col-
oplast AG, Euro Business Center, Blegistrasse 1, CH-
6343 Rotkreuz, Switzerland). Similarly, ischemic
wounds may develop further skin necrosis at the
wound edges and so do not qualify for VT until
revascularization. Finally, VT is contraindicated in
patients with neoplasm, as further tumor growth may
be stimulated by the mechanical stretching that occurs
during VT [25–27].
Vacuum Therapy in Open Fractures
of the Lower Leg
The management of high-energy open fractures con-
tinues to be a difficult problem confronting the surgeon
involved in the treatment of these injuries. Open
fractures have high incidences of malunion and infec-
tion, especially when they involve the tibia [1, 38, 39].
Adequate treatment of the concomitant soft tissue in-
jury is of the highest priority, since it determines the
fate and outcome of bone and extremity. The essential
part of an initial soft-tissue damage treatment is copi-
ous irrigation and thorough debridement, which can
cause significant soft-tissue defects that demand tem-
porary wound coverage followed by secondary wound
closure or reconstructive surgery [3, 40]. Various sur-
gical methods are available in this regard, mainly
including skin grafts, local flaps or free flap transfers
[1].
If possible, the goal is to close open wounds within
the first week in order to quickly cover exposed bone,
tendons and neurovascular structures, which is crucial
if the risk of infection, osteomyelitis, nonunion and
further tissue loss is to be decreased [1]. This, however,
is often impracticable because of a complex fracture,
wound contamination or pre-existing infection. Fur-
thermore, associated injuries accompanied by hemo-
dynamic instability and microcirculatory dysfunction
based on systemic inflammation or edema, as often
seen in polytraumatized patients, prevent early, long-
lasting reconstructive surgical intervention. Although
skin grafts are readily obtainable, they depend on the
vascularity of the recipient site and may be contrain-
dicated by exposed bone, cartilage, tendons or surgical
implants. Therefore, multiple ‘‘second-look’’ opera-
tions are necessary prior to definitive wound closure.
The essential tasks of an appropriate dressing for
temporary wound coverage are to prevent the exposed
vital structures from desiccation and bacterial con-
tamination as well as to induce local proliferation of
granulation tissue. Hence, VT, by sterilizing the wound
and stimulating the formation of granulation tissue, not
only provides adequate temporary wound coverage
before definitive closure but also allows for a much
more flexible time schedule [41].
Fleischmann et al. [6] were the first to report on 15
patients with open fractures treated by vacuum sealing.
It was stated that VT resulted in efficient cleaning and
conditioning of the wound with marked proliferation of
granulation tissue, and that bone infection did not oc-
cur. In 2003, Huang et al. [7] prospectively compared
18 patients with open fractures and soft-tissue defects
treated by primary osteosynthesis, debridement and
VT before definitive wound closure and 14 patients
presenting with similar injuries treated traditionally by
external fixation and open wound management fol-
lowed by secondary osteosynthesis and soft tissue clo-
sure. None of the patients treated by VT showed
complications with the healing of fractures as well as
soft tissue, and there were statistically significant
advantages with regards to time of treatment, total cost
and complication rate in this group. Parrett et al. ret-
rospectively analyzed 290 open tibia–fibula fractures
over a 12-year (1992–2003) period and found a marked
decrease in the need for free flaps for definitive wound
closure in parallel with increased use of VT in the last
four-year period [1]. However, despite this trend, they
found no change in infection, amputation or malunion/
nonunion rates. In contrast, our own group compared
VT to alternative dressing as a temporary coverage for
soft tissue injuries in Gustilo type IIIA and type IIIB
open fractures. VT was used in 14 patients and Epi-
gardTM in 12 patients. Besides one amputation ob-
served in each group, a substantially (although not
statistically significant) smaller infection rate in pa-
tients treated with VT was noted, in spite of higher
morbidity (more type IIIB open fractures and more
polytraumatized patients) [2]. Thus, in this study, VT
seemed to reduce the infection rate in severe open
fractures as compared to alternative temporary wound
dressings.
In general, all of the publications attribute their
successful treatments to the abovedescribed charac-
teristics of VT, such as optimization of blood flow,
decrease of local tissue edema, removal of contami-
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nated wound fluid, as well as stimulation of granulation
tissue formation. However, most of the results must be
interpreted carefully, as these studies lack larger pa-
tient numbers, randomization or even control groups,
and there are considerable differences in the treatment
goals and interpretation of results [11]. Hence, al-
though VT is now regarded as a reasonable and ver-
satile tool for temporary wound coverage in severe
open fractures of the lower extremity, there is still a
considerable deficit of well-designed studies that doc-
ument its efficiency [4]. It cannot be emphasized en-
ough that thorough and repetitive surgical wound
debridement and microvascular flaps remain corner-
stones in the treatment of severe open fractures of the
lower leg. In addition to these, VT should be included
in the management of these injuries for temporary
wound coverage and conditioning of soft tissues. This
has been shown in more recent and methodically im-
proved studies which also demonstrate that although
VT cannot replace free flap transfer, it does allow a
more flexible timeline and it improves safety until
definitive soft tissue closure [2, 5, 7].
Conclusion
Vacuum therapy can be regarded as a reasonable and
versatile tool for temporary wound coverage in severe
open fractures of the lower leg, as it is technically
simple to apply, it is generally well tolerated by pa-
tients, and it has low complication rates. The treatment
success of VT is mainly attributed to optimization of
blood flow, decrease of local tissue edema, reduction of
bacterial count, as well as stimulation of granulation
tissue formation. VT should be included in the man-
agement concept for severe open fractures of the lower
leg since it provides not only safe temporary wound
coverage but also soft-tissue conditioning, allowing for
a more flexible schedule until definitive soft-tissue
coverage. However, despite the obvious clinical sig-
nificance of VT, further studies investigating the
superiority of VT compared to alternative wound
dressings and the exact underlying mechanisms that
lead to the apparent improved wound healing are
needed.
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